NCT01685762View on ClinicalTrials.gov

Metformin for the Treatment of Endometrial Hyperplasia

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

January 10, 2013

Primary Completion Date

December 1, 2015

Study Completion Date

December 1, 2015

Conditions
Endometrial HyperplasiaEndometrial Hyperplasia Without Atypia
Interventions
DRUG

Metformin

850 mg of metformin taken once daily by mouth for 4 weeks (weeks 1-4) and then twice daily by mouth for 8 weeks (weeks 5-12).

Trial Locations (3)

19107

University of Pennsylvania, Philadelphia

27599

The University of North Carolina at Chapel Hill, Chapel Hill

28388

Southern Pines Women's Health Center, Southern Pines

All Listed Sponsors
lead

UNC Lineberger Comprehensive Cancer Center

OTHER

NCT01685762 - Metformin for the Treatment of Endometrial Hyperplasia | Biotech Hunter | Biotech Hunter